Chronological Index of BioCentury, Week in Review: Management Tracks

• China Biologic board of directors update

  China Biologic Products Inc. (NASDAQ:CBPO), Beijing, China Business: Hematology Appointed: David Gao, a director, as chairman; he succeeds Siu Ling Chan, who remains a director

  Published on 4/9/2012

• EntreMed management update

  EntreMed Inc. (NASDAQ:ENMD), Rockville, Md. Business: Cancer, Autoimmune Hired: Ken Ren as interim CEO

  Published on 4/9/2012

• Galena Biopharma management update

  Galena Biopharma Inc. (NASDAQ:GALE), Portland, Ore. Business: Cancer Hired: Rosemary Mazanet as CMO, a partner at Apelles Investment Management LLC

  Published on 4/9/2012

• GenMark Diagnostics management update

  GenMark Diagnostics Inc. (NASDAQ:GNMK), Carlsbad, Calif. Business: Diagnostic Hired: Richard Slansky as CFO, effective April 23, formerly CFO of Digirad Corp.; he succeeds Paul Ross, who is departing

  Published on 4/9/2012

• Good Start Genetics management update

  Good Start Genetics Inc., Cambridge, Mass. Business: Diagnostic Hired: Jean Franchi as CFO, formerly SVP of corporate finance at Genzyme Corp., which Sanofi acquired

  Published on 4/9/2012

• GW Pharma management update

  GW Pharmaceuticals plc (LSE:GWP), Salisbury, U.K. Business: Neurology, Autoimmune Transitioning: Adam George to finance director and a director, effective June 1, from group financial controller while remaining …

  Published on 4/9/2012

• Intarcia management update

  Intarcia Therapeutics Inc., Hayward, Calif. Business: Endocrine/Metabolic, Infectious Transitioned: Kurt Graves to chairman, president and CEO from executive chairman and acting CEO

  Published on 4/9/2012

• Ipsen management update

  Ipsen Group (Euronext:IPN), Boulogne-Billancourt, France Business: Cancer, Endocrine/Metabolic, Neurology Hired: Justin Dillon as VP and chief compliance officer, formerly deputy compliance officer of North America and …

  Published on 4/9/2012

• Knome management update

  KnomeInc., Cambridge, Mass. Business: Genomics Hired: Charles Abdalian as CFO, formerly SVP of finance and CFO of Molecular InsightPharmaceuticals Inc.; Adam Rosenberg as SVP and head of corporate development; Jay …

  Published on 4/9/2012

• NicOx management update

  NicOx S.A. (Euronext:COX), Sophia Antipolis, France Business: Infectious, Cardiovascular, Ophthalmic Hired: Philippe Masquida as EVP and managing director of European operations, formerly VP and head of international …

  Published on 4/9/2012

• Orgenesis management update

  Orgenesis Inc. (OTCBB:ORGS), White Plains, N.Y. Business: Endocrine/Metabolic Hired: Jacob BenArie as CEO, formerly CEO of Beta-Stim Ltd.; Sarah Ferber as CSO, head researcher of the endocrine unit at The Endocrine …

  Published on 4/9/2012

• OvaScience board of directors update

  OvaScience Inc., Boston, Mass. Business: Genitourinary Appointed: John Simon, managing director of General Catalyst

  Published on 4/9/2012

• Summit board of directors update

  Summit Corp. plc (LSE:SUMM), Abingdon, U.K. Business: Musculoskeletal, Endocrine/Metabolic, Infectious Transitioned: Barry Price to non-executive chairman from executive chairman

  Published on 4/9/2012

• Summit management update

  Summit Corp. plc (LSE:SUMM), Abingdon, U.K. Business: Musculoskeletal, Endocrine/Metabolic, Infectious Hired: Glyn Edwards as CEO and a director, formerly CEO of Antisoma plc

  Published on 4/9/2012

• Symphogen management update

  SymphogenA/S, Copenhagen, Denmark Business: Cancer, Hematology, Infectious Hired: Martin Olin as CFO, formerly senior investment director and senior partner at Scandinavia Life Science Invest; he succeeds Thomas …

  Published on 4/9/2012

• Takeda management update

  Takeda Pharmaceutical Co. Ltd. (Tokyo:4502), Osaka, Japan Business: Pharmaceuticals Transitioned: Shinji Honda to SVP of corporate strategy from chief integration officer of Takeda Pharmaceuticals International GmbH; …

  Published on 4/9/2012

• Tonix management update

  Tonix Pharmaceuticals Holding Corp. (OTCBB:TNXP), New York, N.Y. Business: Musculoskeletal, Neurology Hired: Bruce Daugherty as senior director of drug development, a newly created position, formerly a senior research …

  Published on 4/9/2012

• VaxInnate management update

  VaxInnate Corp., Cranbury, N.J. Business: Infectious Hired: Wayne Pisano as president, CEO and a director, formerly president of Sanofi's Sanofi Pasteur vaccines division

  Published on 4/9/2012

• Veracyte management update

  Veracyte Inc., South San Francisco, Calif. Business: Diagnostic Hired: Richard Kloos as senior medical director, formerly a professor of endocrinology, metabolism and nuclear medicine at The Ohio State University

  Published on 4/9/2012

• Durata Therapeutics management update

  Durata Therapeutics Inc., Morristown, N.J. Business: Infectious Hired: John Shannon as chief commercial officer, a newly created position, formerly general manager of global hemophilia and global commercial excellence …

  Published on 4/2/2012

• Intarcia management update

  Intarcia Therapeutics Inc., Hayward, Calif. Business: Endocrine/Metabolic, Infectious Hired: Michelle Baron as CMO and VP of clinical research, formerly VP of diabetes U.S. at Sanofi

  Published on 4/2/2012

• Merck management update

  Merck & Co. Inc. (NYSE:MRK), Whitehouse Station, N.J. Business: Pharmaceuticals Hired: Michael Holston as chief ethics and compliance officer, effective June 25, formerly EVP and general counsel at Hewlett-Packard …

  Published on 4/2/2012

• Vida Diagnostics management update

  Vida Diagnostics Inc., Iowa City, Iowa Business: Diagnostic Hired: Philippe Raffy as chief technology officer

  Published on 4/2/2012

• Vivus management update

  Vivus Inc. (NASDAQ:VVUS), Mountain View, Calif. Business: Endocrine/Metabolic, Genitourinary Hired: Roman Dvorak as senior director of clinical development, formerly VP of clinical development at Ipsen Group's Tercica …

  Published on 4/2/2012

• Warnex management update

  Warnex Inc. (TSX-V:WNX), Laval, Quebec Business: Supply/Service Departing: Francois Jette as CFO

  Published on 4/2/2012